Geoffrey Gurtner
Experienced in Frostbite

Dr. Geoffrey Gurtner

Plastic Surgery
3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
Accepting New Patients
Offers Telehealth
Experienced in Frostbite
3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
OverviewInsuranceLocationsClinical Research

Overview

Outside of clinic, I enjoy running, skiing, golfing and spending time with my family.

Dr. Gurtner is rated as an Experienced provider by MediFind in the treatment of Frostbite. His top areas of expertise are Keloids, Frostbite, Melanoma, Breast Cancer, and Leg or Foot Amputation.

His clinical research consists of co-authoring 271 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Frostbite.

Graduate Institution
University Of California San Francisco School Of Medicine, 1989
Residency
Massachusetts General Hospital, General Surgery, 1997
Specialties
Plastic Surgery
Licenses
Plastic and Reconstructive Surgery in CA
Board Certifications
American Board Of Plastic Surgery
American Board Of Surgery
Fellowships
University of Texas MD Anderson Cancer Center, Microvascular Reconstructive Surgery, 2000
Hospital Affiliations
Banner - University Medical Center Tucson
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Banner - University Medical Center Tucson Campus - Banner University Medicine North
3838 North Campbell Avenue, Building 2, Tucson, AZ 85719
Other Locations
University of Arizona Cancer Center
1891 West Orange Grove Road, Building 1, Tucson, AZ 85704
Banner- University Medicine Multi Specialty Clinic
7165 North Pima Canyon Drive, Tucson, AZ 85718

Additional Areas of Focus

Dr. Gurtner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Melanoma
Breast Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction
A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2026
Intervention Type: Device
Study Phase: Not Applicable
Adjunct Collection of Additional Biorepository Data From Patients Enrolled in DFC Trials
Adjunct Collection of Additional Biorepository Data From Patients Enrolled in DFC Trials
Enrollment Status: Terminated
Publish Date: July 24, 2024
Predictive and Diagnostic Biomarkers for Diabetic Foot Ulcers - C-myc and Phosphorylated Glucocorticoid Receptor
Predictive and Diagnostic Biomarkers for Diabetic Foot Ulcers - C-myc and Phosphorylated Glucocorticoid Receptor
Enrollment Status: Completed
Publish Date: July 12, 2024
Tran-epidermal Water Loss (TEWL) as a Predictive Marker for Diabetic Foot Ulcer (DFU) Recurrence
Tran-epidermal Water Loss (TEWL) as a Predictive Marker for Diabetic Foot Ulcer (DFU) Recurrence
Enrollment Status: Completed
Publish Date: July 21, 2023
Intervention Type: Other
A Multicenter , Prospective, Randomized, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
A Multicenter , Prospective, Randomized, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
Enrollment Status: Completed
Publish Date: November 14, 2022
Intervention Type: Drug
Study Drugs: EscharEx, Gel Vehicle, Non-surgical standard of care
Study Phase: Phase 2
View 4 Less Clinical Trials

271 Total Publications

Optimizing deferoxamine delivery through the skin for pressure ulcers.
Optimizing deferoxamine delivery through the skin for pressure ulcers.
Journal: Expert opinion on drug delivery
Published: December 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gurtner's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile